Monoclonal Anti-pre-Gc protein (SFTS virus (HN6) ) Antibody, Mouse IgG1 (13E1)

• Background:

  Severe fever with thrombocytopenia syndrome (SFTS) is an emerging viral hemorrhagic fever (VHF) endemic to China, South Korea, Japan, and Vietnam. Severe fever with thrombocytopenia syndrome (SFTS) is an infectious disease with a high fatality rate, caused by SFTS virus (SFTSV) . To our knowledge, no efficient SFTSV vaccine exists.

• Description:

  Severe fever with thrombocytopenia syndrome (SFTS) is an emerging viral hemorrhagic fever (VHF) endemic to China, South Korea, Japan, and Vietnam. Severe fever with thrombocytopenia syndrome (SFTS) is an infectious disease with a high fatality rate, caused by SFTS virus (SFTSV) . To our knowledge, no efficient SFTSV vaccine exists.

• Host:

  Hybridoma

• Origin Species:

  Mouse

• Target:

  Glycoprotein C/Gc protein (SFTSV)

• Conjugation:

  Unconjugated

• Tag:

  Mouse IgG1 | Mouse Kappa

• Stability:

  ● -20°C to -70°C for 12 months in lyophilized state; ● -70°C for 3 months under sterile conditions after reconstitution. For long term storage, the product should be stored at lyophilized state at -20°C or lower. Please avoid repeated freeze-thaw cycles.

• Purity:

  90%

• Bioactivity:

  Immobilized SFTS virus pre-Gc Protein (HN6), His Tag (Cat. No. PRN-S52H3) at 1 μg/mL (100 μL/well) can bind Monoclonal Anti-pre-Gc protein (SFTS virus (HN6)) Antibody, Mouse IgG1 (13E1) (Cat. No. PRN-Y315) with a linear range of 0.1-2 ng/mL (QC tested).

• Format:

  Powder

• Buffer:

  PBS, pH7.4

• Additives:

  Trehalose

• Shipping Conditions:

  RT

• Storage Conditions:

  -20°C

• Package Size:

  100ug*1

• Species:

  Mouse

• CAS Number:

  9007-83-4